Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Checkpoint Therapeutics (CKPT) stocks in Canada
Learn how to easily invest in Checkpoint Therapeutics stocks.
Checkpoint Therapeutics is a biotechnology business based in the US. Checkpoint Therapeutics stocks (CKPT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.86 – a decrease of 11.88% over the previous week. Checkpoint Therapeutics employs 10 staff and has a trailing 12-month revenue of around $279,000.
How to buy shares in Checkpoint Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CKPT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Checkpoint Therapeutics?
- Has coronavirus impacted Checkpoint Therapeutics shares?
- Checkpoint Therapeutics shares summary
- Compare share dealing platforms
- Is Checkpoint Therapeutics stock a buy or sell?
- Checkpoint Therapeutics performance over time
- Checkpoint Therapeutics's financials
- How volatile are Checkpoint Therapeutics shares?
- Does Checkpoint Therapeutics pay a dividend?
- Other common questions
Checkpoint Therapeutics stock price (NASDAQ:CKPT)Use our graph to track the performance of CKPT stocks over time.
Checkpoint Therapeutics shares at a glance
|Latest market close||$2.30|
|52-week range||$2.22 - $5.38|
|50-day moving average||$3.21|
|200-day moving average||$3.01|
|Wall St. target price||$15.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.52|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Checkpoint Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Checkpoint Therapeutics price performance over time
|1 week (2022-01-10)||N/A|
|1 month (2021-12-17)||-21.77%|
|3 months (2021-10-18)||-27.22%|
|6 months (2021-07-21)||-22.30%|
|1 year (2021-01-21)||-38.34%|
|2 years (2020-01-21)||17.95%|
|3 years (2019-01-18)||3.6|
|5 years (2017-01-20)||11|
Checkpoint Therapeutics financials
|Gross profit TTM||$-15,283,000|
|Return on assets TTM||-44.87%|
|Return on equity TTM||-88.22%|
|Market capitalisation||$218.6 million|
TTM: trailing 12 months
Checkpoint Therapeutics share dividends
We're not expecting Checkpoint Therapeutics to pay a dividend over the next 12 months.
Checkpoint Therapeutics share price volatility
Over the last 12 months, Checkpoint Therapeutics's shares have ranged in value from as little as $2.22 up to $5.376. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Checkpoint Therapeutics's is 1.6031. This would suggest that Checkpoint Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Checkpoint Therapeutics overview
Checkpoint Therapeutics, Inc. , a clinical-stage immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7. 1 receptors; and CK-302, a human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells. It is also developing CK-101, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a treatment for patients with EGFR mutation-positive non-small cell lung cancer; CK-103, a selective and potent small molecule inhibitor of bromodomain and extra-terminal bromodomains; and anti-carbonic anhydrase IX (CAIX) antibody, a fully human preclinical antibody to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. Checkpoint Therapeutics, Inc. has collaboration agreements with TG Therapeutics, Inc.
Stocks similar to Checkpoint Therapeutics
Checkpoint Therapeutics in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.